Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Aldeyra Therapeutics, Inc. (ALDX)

« Back to company index

ALDX Chatter Timeline

Stock Ticker for ALDX

Most Active Tweeters for ALDX

UserTweets
@TickerReport 3
@fezziwig2008 3
@MareaInformativ 2
@AmericanBanking 2
@bibeypost_stock 2

Recent Tweets for ALDX

fezziwig2008 @fezziwig2008
$ALDX competition for $AGN Buyout- Oyster Point Pharma (private) "The most common adverse events were typical of na… https://t.co/gmew5daUk3
July 15th 2018, 11:07am
bibeypost_stock @bibeypost_stock
Institutional Investor Sentiment About Aldeyra Therapeutics $ALDX Increased - https://t.co/zsupAgT9it
July 15th 2018, 10:07am
TickerReport @TickerReport
Analyzing Aldeyra Therapeutics $ALDX and Diffusion Pharmaceuticals $DFFN https://t.co/w2OH6vCrMy
July 15th 2018, 8:07am
dakotafinancial @dakotafinancial
-$0.39 Earnings Per Share Expected for Aldeyra Therapeutics, Inc $ALDX This Quarter https://t.co/3DRV4DXN7K
July 15th 2018, 2:07am
TickerReport @TickerReport
Aldeyra Therapeutics, Inc $ALDX Expected to Post Earnings of -$0.39 Per Share https://t.co/XtUN1Q0O3H
July 15th 2018, 2:07am
fezziwig2008 @fezziwig2008
@drlopez0108 The mech of action of $AGN Restasis is not well understood. $ALDX Repraxalap's is well spelled out. Re… https://t.co/z5A4PPb0o0
July 14th 2018, 5:07pm
bibeypost_stock @bibeypost_stock
EPS for Aldeyra Therapeutics, Inc. $ALDX Expected At $-0.39 - https://t.co/QQ87HeXlad
July 14th 2018, 4:07am
reurope_stock @reurope_stock
Analysts See $-0.39 EPS for Aldeyra Therapeutics, Inc. $ALDX https://t.co/ibxQxBsGQN
July 14th 2018, 4:07am
mmahotstuff1 @mmahotstuff1
$-0.39 EPS Expected for Aldeyra Therapeutics, Inc. $ALDX - https://t.co/3yQ63be1MI
July 14th 2018, 4:07am
whatsonthorold2 @whatsonthorold2
Aldeyra Therapeutics, Inc. $ALDX Analysts See $-0.39 EPS - https://t.co/12d3gpkuTB
July 14th 2018, 4:07am
reurope_stock @reurope_stock
Here's how analysts see Aldeyra Therapeutics, Inc. $ALDX after this past week. https://t.co/qTNnyIJ3r0
July 13th 2018, 1:07pm
Ligand_LGND @Ligand_LGND
$ALDX announces last patient dosed in dry eye disease Phase 2b clinical trial of topical ocular reproxalap https://t.co/QuViqPbvot
July 13th 2018, 12:07pm
YuZhu4 @YuZhu4
RT @fezziwig2008: $AGN Restasis Patent fail will fit into $ALDX P2b data release like a Duncan Phyfe Dovetail... https://t.co/Wm395ozxWX
July 13th 2018, 12:07am
AmericanBanking @AmericanBanking
-$0.39 EPS Expected for Aldeyra Therapeutics, Inc $ALDX This Quarter https://t.co/0bT6J8wrEE #stocks
July 13th 2018, 12:07am
TheMarketsDaily @TheMarketsDaily
Aldeyra Therapeutics, Inc $ALDX Expected to Announce Earnings of -$0.39 Per Share https://t.co/ngKIyCtMgF
July 13th 2018, 12:07am
fezziwig2008 @fezziwig2008
$AGN Restasis Patent fail will fit into $ALDX P2b data release like a Duncan Phyfe Dovetail... https://t.co/Wm395ozxWX
July 12th 2018, 8:07pm
MaisaCorp @MaisaCorp
$ALDX the last patient has completed dosing in the company's phase 2b clinical trial of topical ocular reproxalap… https://t.co/FjzgPXHjmf
July 12th 2018, 3:07pm
StockNewsNow @StockNewsNow
$ALDX Aldeyra Therapeutics Announces Last Patient Dosed in Dry Eye Disease Phase 2b Clinical Trial https://t.co/cotWTprV7S
July 12th 2018, 11:07am
ErikOtto2 @ErikOtto2
RT @odibro: $ALDX Announces Last Patient Dosed in Dry Eye Disease Phase 2b Clinical Trial. Data later in 2018 https://t.co/FUM1so0MIT
July 12th 2018, 9:07am
odibro @odibro
$ALDX Announces Last Patient Dosed in Dry Eye Disease Phase 2b Clinical Trial. Data later in 2018 https://t.co/FUM1so0MIT
July 12th 2018, 8:07am
greenpenny2016 @greenpenny2016
$ALDX - Aldeyra Therapeutics Announces Last Patient Dosed in Dry Eye Disease Phase 2b Clinical Trial https://t.co/U8DcI0aB9e
July 12th 2018, 8:07am
Ultra_Calls @Ultra_Calls
$ALDX Aldeyra Therapeutics Reports Last Patient Dosed in Dry Eye Disease Phase 2b Clinical Trial, Results Expected To Be Announced 2018
July 12th 2018, 8:07am
dakotafinancial @dakotafinancial
Aldeyra Therapeutics, Inc $ALDX Receives Average Rating of “Buy” from Brokerages https://t.co/DoF5WrTadi
July 8th 2018, 4:07pm
WatchlistN @WatchlistN
Aldeyra Therapeutics, Inc $ALDX Receives $22.67 Consensus Target Price from Analysts https://t.co/WYkD2BL08V
July 6th 2018, 1:07pm
TickerReport @TickerReport
Analysts Set Aldeyra Therapeutics, Inc $ALDX Target Price at $22.67 https://t.co/KXUJp8Nu2s
July 6th 2018, 1:07pm
MrCDanso @MrCDanso
$ALDX Strong ? for a thin float. I see you @fezziwig2008 ?
July 3rd 2018, 11:07am
MareaInformativ @MareaInformativ
Aldeyra Therapeutics, Inc $ALDX Given Consensus Rating of “Buy” by Brokerages https://t.co/arhNQtbWDx
July 3rd 2018, 6:07am
AmericanBanking @AmericanBanking
Aldeyra Therapeutics, Inc $ALDX Given Consensus Rating of “Buy” by Brokerages https://t.co/tzxm2oDaM3 #stocks
July 3rd 2018, 2:07am
MareaInformativ @MareaInformativ
Zacks: Brokerages Anticipate Aldeyra Therapeutics, Inc $ALDX Will Announce Earnings of -$0.39 Per Share https://t.co/XSnlDgHUGq
July 3rd 2018, 12:07am
dakotafinancial @dakotafinancial
Aldeyra Therapeutics, Inc $ALDX Expected to Announce Earnings of -$0.39 Per Share https://t.co/IlmEToEHVl
June 30th 2018, 11:06am
ThisLincolnian @ThisLincolnian
Aldeyra Therapeutics $ALDX Rating Reiterated by Cantor Fitzgerald https://t.co/nn5VdaouRf
June 30th 2018, 6:06am
WatchlistN @WatchlistN
Aldeyra Therapeutics $ALDX Rating Reiterated by Cantor Fitzgerald https://t.co/dGkHgx8ggX
June 30th 2018, 1:06am
TickerReport @TickerReport
Aldeyra Therapeutics’ $ALDX “Buy” Rating Reiterated at Cantor Fitzgerald https://t.co/sc0jRnxZZK
June 29th 2018, 5:06pm
popastock @popastock
RT @fezziwig2008: $ALDX “ $NVS is looking outside the company to broaden its gene-therapy program, concentrating on cancer, neuroscience an…
June 29th 2018, 2:06pm
fezziwig2008 @fezziwig2008
$ALDX “ $NVS is looking outside the company to broaden its gene-therapy program, concentrating on cancer, neuroscie… https://t.co/G2f7F4m7mv
June 29th 2018, 7:06am
fezziwig2008 @fezziwig2008
$ALDX "Allergy Treatment- The Next Logical Step- Aldehyde Trapping" https://t.co/eUiU2GA71S https://t.co/YJot26Mldj
June 28th 2018, 11:06pm
TheMarketsDaily @TheMarketsDaily
Analysts Expect Aldeyra Therapeutics, Inc $ALDX to Announce -$0.39 EPS https://t.co/2vRKEfV6KU
June 28th 2018, 12:06pm
fezziwig2008 @fezziwig2008
@MrCDanso $ALDX -Can just reiterate #CantorFitzgerald-"anticipate significant catalysts w reproxalap from upcoming… https://t.co/P0Xi7e2NjM
June 28th 2018, 8:06am
MrCDanso @MrCDanso
$TRXC and $ALDX both added to the Russell, the former run up about 50% while the latter is down nearly 20%. @fezziwig2008 ????
June 28th 2018, 8:06am
OlympiaReport @OlympiaReport
Cantor Fitzgerald Reiterates Buy Rating for Aldeyra Therapeutics $ALDX https://t.co/MfN44YfBcj
June 28th 2018, 2:06am
bibeypost_stock @bibeypost_stock
Aldeyra Therapeutics $ALDX: Cantor Fitzgerald Reiterates Buy Rating Today, Has a Target of $23.0000/Share - https://t.co/mf0UAsH5Xb
June 27th 2018, 11:06am
presstelegraph1 @presstelegraph1
Aldeyra Therapeutics $ALDX: Cantor Fitzgerald Reiterates "Buy" Rating Today, Has a Target of $23.0000/Share https://t.co/L9V1l5VMew
June 27th 2018, 10:06am
finnewsdaily @finnewsdaily
TOday’s Movers: Aldeyra Therapeutics $ALDX Stock Rating Reiterated by Analysts at Cantor Fitzgerald; $23.0000 Targe… https://t.co/rZbUdg2kAD
June 27th 2018, 10:06am
weeklyhub @weeklyhub
Key Equity Analysts at Cantor Fitzgerald Didn't Change their ‘Buy’ rating for Aldeyra Therapeutics $ALDX Shares Tod… https://t.co/7AZBsa0XHJ
June 27th 2018, 10:06am
kldaily_stock @kldaily_stock
Key Analysts at Cantor Fitzgerald Reiterated their ‘"Buy"’ rating for Aldeyra Therapeutics $ALDX Shares Today. Thei… https://t.co/FTYwLmoTup
June 27th 2018, 10:06am
bibeypost_stock @bibeypost_stock
Here's how analysts see Aldeyra Therapeutics, Inc. $ALDX after this past week. - https://t.co/LHu24dFP3Q
June 27th 2018, 9:06am
reurope_stock @reurope_stock
Analysts are on the Bearish side about Aldeyra Therapeutics, Inc. $ALDX this week. https://t.co/I2f73MNusc
June 27th 2018, 9:06am
presstelegraph1 @presstelegraph1
How Analysts Rated Aldeyra Therapeutics, Inc. $ALDX Last Week? https://t.co/wvqD8ucJDv
June 27th 2018, 9:06am
finnewsdaily @finnewsdaily
Were Analysts Bearish Aldeyra Therapeutics, Inc. $ALDX This Week? https://t.co/tAB6Zbgzj9
June 27th 2018, 9:06am
weeklyhub @weeklyhub
Can analysts adopt a bullish outlook for Aldeyra Therapeutics, Inc. $ALDX? https://t.co/AnRGJm5AIM
June 27th 2018, 9:06am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.